Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1129266

	registered interest
	date	03/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Hearing Impairment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of mental health support for people who (a) are deaf and (b) have a hearing impairment; and if he will make a statement.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	258972
	answer	answer is ministerial correction date of answer 06/06/2019 answer text <p>The Government is committed to ensuring that all people who have a mental health need, including those who are deaf or have a hearing impairment, are able to access appropriate support when they need it regardless of other physical health conditions. Commissioners are responsible for commissioning appropriate cultural and linguistic provisions when planning services for deaf people.</p><p>Deaf patients are able to access mental health services based on a clinical assessment of need with the support and involvement of clinicians (including consultant psychiatrists and mental health nurses) with the skills and experience of working with deaf people with mental illness and who are able to communicate using British Sign Language (BSL) where needed.</p><p>NHS England commissions specialised mental health services for children, young people and adults who are deaf or have a hearing impairment. These include inpatient and outreach services for children and young people and services for adults who require inpatient care, including care in secure mental health services.</p><p>The Specialised Mental Health Clinical Reference Group provides advice and support to NHS England about improving commissioning, including through service specifications and quality schemes. NHS England has developed a specific Commissioning for Quality and Innovation (CQUIN) scheme in 2019-20 for specialised deaf services aimed at introducing a standardised approach to the assessment and understanding of a patient’s individual communication skills, which will improve the effectiveness of interactions with staff, care planning and delivery.</p><p>The Joint Commissioning Panel for Mental Health has published guidance for commissioners of primary care mental health services for deaf people. This is for use by clinical commissioning groups, local authorities and service providers across primary and secondary care. The content is evidence based and incudes what is deemed to be best practice when commissioning mental health services for deaf people. The guide is available at the following link:</p><p><a href="http://www.improvement.nhs.uk/resources/improving-mental-health-services-for-deaf-people/" target="_blank">www.improvement.nhs.uk/resources/improving-mental-health-services-for-deaf-people/</a></p><p>The guidance recommends the training of psychological wellbeing practitioners through an accredited standard Improving Access to Psychological Therapies low intensity training course adapted for delivery in BSL. It also sets out the benefit of providing the current specialist BSL workforce with access to continuing professional development training so that they are able to further develop their skills and expertise through programmes such as high intensity therapy, counselling for depression, supervision qualifications and other appropriate interventions.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 258975 question first answered 06/06/2019 15:37:32 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	298 label Biography information for Steve McCabe

1129267

	registered interest
	date	03/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Counselling: Sign Language
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the availability of deaf-focused NHS counselling using British sign language as the first language in England; and if he will make a statement.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	258973
	answer	answer is ministerial correction date of answer 06/06/2019 answer text <p>The National Health Service Improving Access to Psychological Therapies (IAPT) programme is available to all adults. If an individual is deaf and requires British Sign Language (BSL) to be used, services can either use a BSL interpreter or refer them to Sign Health, an IAPT service which delivers therapy using BSL trained therapists. Sign Health is available nationally but is funded via individual funding requests, so clinical commissioning groups (CCGs) are responsible for funding decisions. In 2018/19 Sign Health received £1 million from 116 CCGs for the treatment of around 250 people. Other alternatives that may be suitable for deaf people include therapy delivered via a digital route, for example text messaging.</p><p>The NHS England IAPT manual, published in June 2018, specifies that commissioners, managers, primary and secondary care clinicians should develop local IAPT care pathways in consultation with patient groups and community leaders, including under-represented groups. The IAPT manual recommends that commissioners and providers consider commissioning services that have bilingual clinicians who speak the language of local minority groups, including clinicians who are fluent in BSL for deaf people.</p><p>Local commissioners have to pay due regard to the equality legislation when commissioning IAPT services. They are able to decide whether they meet their responsibilities through services who provide BSL trained therapists or through interpreters in their locality.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 06/06/2019 16:11:41 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	298 label Biography information for Steve McCabe

1129269

	registered interest
	date	03/06/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Mental Health Services: Hearing Impairment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what (a) guidance and (b) training is available to clinicians on assessing and referring deaf patients to specialist mental health support.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	258975
	answer	answer is ministerial correction date of answer 06/06/2019 answer text <p>The Government is committed to ensuring that all people who have a mental health need, including those who are deaf or have a hearing impairment, are able to access appropriate support when they need it regardless of other physical health conditions. Commissioners are responsible for commissioning appropriate cultural and linguistic provisions when planning services for deaf people.</p><p>Deaf patients are able to access mental health services based on a clinical assessment of need with the support and involvement of clinicians (including consultant psychiatrists and mental health nurses) with the skills and experience of working with deaf people with mental illness and who are able to communicate using British Sign Language (BSL) where needed.</p><p>NHS England commissions specialised mental health services for children, young people and adults who are deaf or have a hearing impairment. These include inpatient and outreach services for children and young people and services for adults who require inpatient care, including care in secure mental health services.</p><p>The Specialised Mental Health Clinical Reference Group provides advice and support to NHS England about improving commissioning, including through service specifications and quality schemes. NHS England has developed a specific Commissioning for Quality and Innovation (CQUIN) scheme in 2019-20 for specialised deaf services aimed at introducing a standardised approach to the assessment and understanding of a patient’s individual communication skills, which will improve the effectiveness of interactions with staff, care planning and delivery.</p><p>The Joint Commissioning Panel for Mental Health has published guidance for commissioners of primary care mental health services for deaf people. This is for use by clinical commissioning groups, local authorities and service providers across primary and secondary care. The content is evidence based and incudes what is deemed to be best practice when commissioning mental health services for deaf people. The guide is available at the following link:</p><p><a href="http://www.improvement.nhs.uk/resources/improving-mental-health-services-for-deaf-people/" target="_blank">www.improvement.nhs.uk/resources/improving-mental-health-services-for-deaf-people/</a></p><p>The guidance recommends the training of psychological wellbeing practitioners through an accredited standard Improving Access to Psychological Therapies low intensity training course adapted for delivery in BSL. It also sets out the benefit of providing the current specialist BSL workforce with access to continuing professional development training so that they are able to further develop their skills and expertise through programmes such as high intensity therapy, counselling for depression, supervision qualifications and other appropriate interventions.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency Thurrock answering member printed Jackie Doyle-Price grouped question UIN 258972 question first answered 06/06/2019 15:37:32 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	298 label Biography information for Steve McCabe

1126906

	registered interest
	date	15/05/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Paediatrics: Staff
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will support the Children and Young People's Transformation Programme within the NHS Long Term Plan by (a) publishing the Government's timetable for the implementation of the paediatric Workforce Implementation Plan and (b) guaranteeing that the Workforce Implementation Plan will be fully-funded from the public health budget.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	254728
	answer	answer is ministerial correction date of answer 20/05/2019 answer text <p>I refer the hon. Member to the answer I gave on 7 May 2019 to Question <a href="https://www.parliament.uk/business/publications/written-questions-answers-statements/written-question/Commons/2019-04-30/249197/" target="_blank">249197</a>.</p><p> </p><p>Whilst there are no plans for a specific ‘paediatric Workforce Implementation Plan’, the NHS People Plan will include those working with children and young people. A final Plan will be published following the 2019 Spending Review.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 20/05/2019 14:31:49 answering member 1585 label Biography information for Stephen Hammond
	tabling member	298 label Biography information for Steve McCabe

1123944

	registered interest
	date	30/04/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Children and Young People
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the Children and Young People's Transformation Programme in the NHS Long Term Plan, published in January 2019, if he will publish the timeframe for the implementation of the essential paediatric Workforce implementation plan; and take steps to ensure that the workforce implementation plan will be funded from the public health budget.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	249197
	answer	answer is ministerial correction date of answer 07/05/2019 answer text <p>The National Health Service budget will increase by £33.9 billion in cash terms, the equivalent of £20.5 billion in real terms by 2023/24, reflecting the fact that the NHS is the Government’s top spending priority.</p><p>The NHS Long Term Plan prioritises services for children and young people. It provides a clear focus on improving the health of children and young people across mental health, learning disabilities, cancer and elsewhere. It is critical in prioritising services for children and young people in future, and it will continue to influence the wider issues that impact on children’s health. Creation of a Transformation Programme for Children and Young People will provide an improved strategic and coordinated response to meet the diverse needs of children and young people.</p><p>My Rt. Hon. Friend the Secretary of State for Health and Social Care has asked Baroness Harding to take forward the development of a People Plan, as part of the overall implementation plan for the Long Term Plan, in order to ensure the challenges of supply, reform, culture and leadership can be met. This will sit alongside the broader Implementation Plan that will be developed at all levels to make the Long Term Plan a reality. An interim People Plan will be published this spring and a full plan will be published within two months of the conclusion of the Spending Review.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 07/05/2019 16:09:07 answering member 1585 label Biography information for Stephen Hammond
	tabling member	298 label Biography information for Steve McCabe

1088497

	registered interest
	date	13/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Innovation
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what his plans are for the future of NHS England’s Commissioning through Evaluation programme.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	231897
	answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>The Commissioning through Evaluation programme is led by NHS England. The programme opened in 2014, with a small number of initial schemes established to generate material new data to support clinical commissioning policy formation for potentially promising specialised treatments. The evaluative commissioning programme continues to develop based on the learning from these early pilot areas. The future developments of the programme are the responsibility of NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 21/03/2019 16:24:45 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

1088498

	registered interest
	date	13/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Treatments: Technology
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the regional variation in the uptake of MedTech products across the NHS.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	231898
	answer	answer is ministerial correction date of answer 21/03/2019 answer text <p>Through the Accelerated Access Review, the NHS Long Term Plan and the second Life Sciences Sector Deal, the Government and the National Health Service have confirmed their commitment that, where appropriate, all patients should be able to benefit from the best treatments as fast as possible. To deliver on this, we have announced a number of measures to improve the spread of health tech innovations:</p><p> </p><p>- Strengthening the Innovation Scorecard, the national tool that measures the uptake of cost effective innovations approved by the National Institute for Health and Care Excellence (NICE), and widening the range of medtech products it covers;</p><p>- From 2020, a new NHS England health tech funding requirement will identify the best value innovations as ‘ready to spread’ and help the NHS to adopt them quickly. This will apply to health tech products assessed as cost saving by NICE. In addition, NICE will significantly increase the number of evaluations it does for health tech products, so that the NHS has the evidence it needs to decide the best products to adopt and spread;</p><p>- The Accelerated Access Collaborative, under the chairmanship of Lord Darzi, will be expanded to be the umbrella organisation across the innovation landscape in the United Kingdom, tackling the system wide-barriers that cause unwarranted variation in the level of access for patients;</p><p>- The regional network of Academic Health Science Networks (AHSNs) will also continue to be a key partner in adoption and spread of health technology. AHSNs bring together the assets in their regions to drive innovation uptake and support local service transformation, promoting health equality, best practice and transformation in leadership, quality and safety of care; and</p><p>- These approaches build on NHS Improvement’s Getting It Right First Time and NHS RightCare initiatives, which seek to improve the quality of care within the NHS by reducing unwarranted variation.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 21/03/2019 12:15:58 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	298 label Biography information for Steve McCabe

1083740

	registered interest
	date	07/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Metoprolol
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps he has taken to ensure the continued availability of the Beta Blocker Metoprolol for people who are prescribed this medicine on the NHS.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	229619
	answer	answer is ministerial correction date of answer 15/03/2019 answer text <p>The Department is aware of a supply issue affecting metoprolol 50mg and 100mg tablets. The issue has been caused due to some manufacturers discontinuing the products and other manufacturers experiencing supply difficulties. Limited supplies of both strengths of tablet are currently available. While further deliveries of both the 50mg and 100mg tablet are expected to be released to the United Kingdom market during March, supplies of metoprolol are likely to be intermittent for a number of months.</p><p> </p><p>The Department has worked with NHS England, NHS Improvement, UK Medicines Information and specialist clinicians to develop guidance for clinicians to use with their patients, who may be affected by this supply issue. The guidance outlines management options, including the use of alternative beta blockers and monitoring requirements during switching, should this be necessary. Information about this supply issue and the clinical guidance has been cascaded through primary and secondary care networks in the NHS. Departmental officials are working with all manufacturers of metoprolol to resolve the situation as quickly as possible and will continue to monitor the supply situation for all beta blockers closely.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/03/2019 13:27:33 answering member 4067 label Biography information for Steve Brine
	tabling member	298 label Biography information for Steve McCabe

1082617

	registered interest
	date	06/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Selective Serotonin Reuptake Inhibitors
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what guidance his Department has issued to health professionals that prescribe Selective Serotonin Reuptake Inhibitors on advice to patients on the potential for (a) erectile dysfunction and (b) other side effects after patients have stopped taking that medication.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	229085
	answer	answer is ministerial correction date of answer 14/03/2019 answer text <p>Selective Serotonin Reuptake Inhibitors (SSRIs) are authorised for the treatment of depression and anxiety disorders.</p><p> </p><p>Information about possible side-effects associated with treatment are provided in the product information which is available to all prescribers and patients. All SSRIs include sexual dysfunction (problems with erection or ejaculation) within the list of possible side effects. The Medicines and Healthcare products Regulatory Agency (MHRA) is contributing to an ongoing European review of persistent sexual dysfunction for all SSRI medicines.</p><p> </p><p>All SSRIs may be associated with withdrawal reactions on stopping or reducing treatment and product information for healthcare professionals and patients includes advice on gradual withdrawal of treatment and management of symptoms.</p><p> </p><p>In addition to the product information which is approved by the MHRA, communications and guidance may be issued to raise awareness of particular safety concerns. Information about possible withdrawal reactions and the need to gradually reduce the dose when stopping treatment was issued in 2004 and subsequently incorporated into general guidance published on the MHRA website in 2014.</p><p> </p><p>The safety of SSRIs is continually monitored by the MHRA.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 14/03/2019 16:04:22 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	298 label Biography information for Steve McCabe

1078637

	registered interest
	date	27/02/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Standards
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has plans to undertake a public consultation on the proposed review of NHS performance times.
	tabling member constituency	Birmingham, Selly Oak
	tabling member printed	Steve McCabe
	uin	226519
	answer	answer is ministerial correction date of answer 04/03/2019 answer text <p>The clinically-led review of standards was announced by the Prime Minister in June 2018. The review is considering the appropriateness of operational standards for physical and mental health relating to planned, unplanned urgent or emergency care, as well as cancer.</p><p>The Long Term Plan provides a platform upon which innovative models of patient care can and are being developed. In that context, the National Health Service’s National Medical Director has been working with the Academy of Medical Royal Colleges, Healthwatch England and many others to consider what matters most to patients, on the clinical issues with the current target regime, and what NHS staff believe will help them provide the best quality care for patients.</p><p>The review will report its interim findings in the spring of 2019, after which any recommended changes will be carefully tested across the NHS and be subject to a rigorous approach before they are implemented.</p><p>We are committed to ensuring that any potential changes to NHS performance standards are based on clinical evidence, and work in the interest of patient safety. If new standards are implemented they will not diminish current performance standards.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 04/03/2019 17:39:54 answering member 1585 label Biography information for Stephen Hammond
	tabling member	298 label Biography information for Steve McCabe